Salmeterol xinafoate is primarily used as a long-acting beta-agonist (LABA) in the management of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, making it easier to breathe. This medication is often prescribed for patients who require regular treatment to control their symptoms and prevent asthma attacks or COPD exacerbations. It is typically administered via inhalation using a metered-dose inhaler or a dry powder inhaler. Salmeterol xinafoate is usually combined with an inhaled corticosteroid to provide both immediate and long-term control of airway inflammation and bronchoconstriction. It is not intended for use as a rescue medication during acute episodes of breathing difficulty. Patients are advised to follow their healthcare provider’s instructions carefully to achieve optimal results and minimize potential side effects.